X-Message-Number: 4879
Date: Sun, 17 Sep 1995 07:17:37 -0700 (PDT)
From: Doug Skrecky <>
Subject: desiccation as cryonic insurance

                  DESSICATION AS CRYONIC INSURANCE
               (From Longevity Report 38 April 1993)
                       By Doug Skrecky
  (Note: The British spell the word "desiccation" as "dessication".)

     If financial concerns preclude continued liquid nitrogen suspension
 at some point in the future it would be helpful to have a backup plan in
 place ahead of time so as to prevent the destruction of the cryonics
 "patient". The only alternative backup technique capable of long term
 preservation is complete desiccation. This must be achieved with a
 minimum of damage to cryopreserved tissues in order to keep reanimation
 chances alive, yet be inexpensive enough to be feasible on a limited
 budget. 
     Freezing requires cryoprotectants to preserve tissue. Similarly
 desiccation requires anhydroprotectants to preserve tissue. Fortunately
 there do exist two cryoprotectants which can also serve as
 anhydroprotectants. One of these is the sugar trehalose. Recently
 trehalose has been found to outperform all other cryoprotectants in its
 ability to enable 80% of frozen organisms (tardigrades) to revive. *1 No
 other tested cryoprotectant comes even close to this performance. Thus
 trehalose would appear set to replace all other cryoprotectants, except
 for one significant defect. It is very, very expensive. Fortunately the
 other dual cryoprotectant/anhydroprotectant is sucrose or common table
 sugar. So as a starting point we will assume that a large amount of
 sucrose in used in the cryo-perfusiate so that desiccation without
 massive tissue destruction would then be a possibility. 
     Desiccation requires that all water be removed from tissue. This
 could be achieved by thawing the patient, embalming and then air drying
 at room temperature at a negligible expence. Unfortunately the chances
 for reanimation would then also appear to be negligible. Vaccuum freeze
 drying could be used instead, but then the cost would be prohibitive. 
 Solvents such as methanol or acetone have been used to thaw small frozen
 tissue blocks at -80 C with good results. *2 *3 Although at room
 temperature these solvents dissolve lipids and fix proteins, at low
 temperatures these effects are largely prevented, although some DNA
 denaturation still occurs. Unfortunately when larger tissue blocks are
 used, which require longer substitution times tissue deterioration does
 occur, which requires fixatives to prevent. *4 DMSO/water mixtures have
 preserved tissue quite well for an extended period at low temperatures,
 but have virtually no ability to extract moisture from tissue. *5
 Dimethyformamide has looked promising in a preliminary experiment, but
 this solvent has a high boiling point, so it would be of little use as
 ALL solvents must be removed before tissue could be said to be truly
 desiccated and inert. *6 Tetramethylsilane is an inert liquid, has a low
 .3 C boiling point and it has recently been proved to be superior to
 acetone as a substitution medium. *7 However the best medium overall may
 well be any dry inert gas. 
     A vaccuum increases drying rates because it (like solvents)
 eliminates the barrier to diffusion that meniscus effects create during
 air drying.  However diffusion is only a problem with large blocks of
 tissue. *8 By using the cardiovascular system as a drying surface the
 problem of diffusion through tissue is avoided and simultaneously the
 total surface area available for sublimation is increased by over 300
 times. Internal desiccation with an inert gas would have the same result
 as vaccuum freeze drying, but at a tiny fraction of the price. Of the
 inert gases desiccation has been found to proceed most rapidly with the
 lightest -helium. 
     The patient could be prepared for such a possible future internal
 desiccation by removing all of the liquid cryoperfusiate from the
 cardiovascular system immediately prior to cryonic suspension. If this
 system is intact infusion with a mildly pressurised inert gas would
 force out the any fluids and simultaneously prevent collapse of veins
 and arteries. If the cardiovascular system is not intact any nontoxic
 liquid with a low freezing point could be used to replace the
 cryoperfusiate. The tissue could then be frozen at a temperature which
 is still above the freezing point of this liquid, which would then be
 drained off before nitrogen suspension itself.  What about those
 already frozen without anhydroprotectants? Could these patients also be
 desiccated in the future without massive tissue damage? The answer to
 this will require some further research, but the provisional answer
 appears to be yes. Provided the patient is first thawed at close to
 freezing temperatures and immediately perfused with a sugar based
 transplantation solution only a modest amount of deterioration should
 occur. Then the body could be refrozen before drying or even desiccated
 without further freezing (or freezing damage). Drying at close to but
 above freezing temperatures occurs more rapidly since liquid water can
 evaporate much faster than ice can sublimate. *9

 *1 "Survival of the Cryptobiotic Eutarigrade Adorybiotus Coronifer During
 Cooling to -196 C:Effect of Cooling Rate, Trehalose Level and Short-term
 Acclimation" 125-130 Vol.29 1992 Cryobiology
 *2 "Freeze-Substitution Without Aldehyde or Osmium Fixatives: 
 Ultrastructure and Implications for Immunocytochemistry" 355-363 Vol.158
 1990 Journal of Microscopy
 *3 "Immunoelectron Microscopy of Tissues Processed by Rapid Freezing and
 Freeze-substitution Fixation Without Chemical Fixatives: Application to
 Catalase in Rat Liver Hepatocytes" 617-623 Vol.38 No.5 1990
 *4 "Freeze-substitution Techniques for Preparing Nematodes for Scanning
 Electron Microscopy" 187-196 Vol.164 1991 Journal of Microscopy
 *5 "Effects of Electrolyte Composition and pH on the Structure and
 Function of Smooth Muscle Cooled to -79 C in Unfrozen Media" 82-100 Vol.9
 1972 Cryobiology
 *6 "Improved Cryoprotection and Freeze-substitution of Embryonic Quail
 Retina: A TEM Study on Ultrastructural Preservation" 348-356 Vol.1 1990
 Journal of Electron Microscopy Technique
 *7 "An Evaluation of the Usefulness of Air-Drying Biological Samples From
 Tetramethysilane in Preparation for Scanning Electron Microscopy" 198-202
 Vol.40 1991 Journal of Electron Microscopy
 *8 "Freeze Drying Without Vaccuum: A Preliminary Investigation 94-96
 January 1962 Food Technology
 *9 "Controlled Low-Temperature Vaccuum Dehydration- A New Approach for
 Low-Temperature and Low Pressure Food Drying" 1573-1579 Vol.54 No.6 1989
 Journal of Food Science

  .....I now find a variety of faults in the above article. Perhaps from
 the standpoint of cryonicists the most serious deficiency is my
 implication that trehalose is a superior cryoprotectant. Unfortunately
 although excellent results have been obtained with tardigrades this does
 imply that similar results would be obtained with human tissue treated
 with trehalose. The difference is that tardigrade cell membranes have an
 active transport mechanism for ferrying sugars from the inside to the
 outside of cells. In human cells trehalose and sucrose are almost
 completely impermeable to the cell membranes. There do however exist
 other anhydroprotectants that are slightly permeable such as mannitol. I
 will have something more to say about this later....


Rate This Message: http://www.cryonet.org/cgi-bin/rate.cgi?msg=4879